Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

From the Desk of Avigdor Kaplan

Director General
Hadassah Medical Organization

Dear Hadassah Family,

Rosh Hashanah is practically upon us bringing with it reflections on the year that has transpired and anticipation of the year to come. In a way, for me, the New Year also began on June 1st when I became Director General of the Hadassah Medical Organization. Approaching this new role involved a great deal of thought. Among the first things I undertook was a thorough analysis of HMO's structure.

In thinking about the future, I was determined to find a new approach to the management and administration of our Medical Center. I came to Hadassah incredibly impressed with the expertise and excellence of the men and women on both our campuses. Every day I learn of another research accomplishment or another innovative initiative in patient care and I am even more impressed. At the same time, I was convinced a better way could be found to take full advantage of the talents and skills of our extraordinary staff and put our entire institution on a firmer footing.

Sometimes an outsider can see solutions those involved cannot. No longer quite an outsider, I have created a rather simple schematic that clarifies chains of command and more clearly delineates areas of responsibility. I believe that the new organizational structure further enhances HMO's amazing ability to provide the finest in healing, teaching and research.

I would like to share with you some of the strategic points of this plan. Among our first steps was an overhaul of the administrative structure. This was followed by a complete reorganization of our Medical Services, taking advantage of our wealth of accomplished and experienced medical personnel. The new structure is designed to clarify the hierarchy of authority and responsibility while simplifying and streamlining processes and procedures – at no additional cost.

I am pleased that two of our leading doctors will head the Medical Management Team, serving as Senior Deputy Directors General, and reporting to the Director General. Even before their appointments were announced, they began working together closely, meeting to exchange ideas, consider current issues and discuss our vision for the future. Both are excited by the dramatic opportunities the new format represents and have embraced it wholeheartedly.

As Senior Deputy Director General of Medical Services, Dr. Yuval Weiss will oversee all medical matters at both Hadassah hospitals, while continuing as Director of Hadassah-Ein Kerem.

As Senior Deputy Director General of Research and Academic Affairs, Prof. Yaakov Naparstek will be responsible for developing, guiding and supervising all HMO research and academic activities. This new position was created to enhance and expand HMO's national and international prominence in translational research and develop even more extensive relationships and collaborations with leading medical centers world-wide. To further bolster these efforts, it will include the Division of Research and Development and Hadasit, HMO's technology transfer company.

Hadassah's broad spectrum of medical and surgical specialties and sub-specialties puts us on par with leading medical centers around the world. To be even better equipped to provide the finest in patient care we have reorganized the medical and surgical departmental structure into 14 clearly-defined Divisions, which are listed at the end of this letter.

We decided this would be best accomplished by grouping departments and units, specialties and sub-specialties, according to the parts of the body they treat. Once again, Hadassah has taken a bold and innovative step forward creating unified medical and surgical Divisions. Now we have multi-disciplinary teams working together to provide our patients more comprehensive care and enhance more collaborative research efforts.

It is often true as conventional wisdom maintains that, change is not easy. However, I must tell you that when we announced the new framework, it was greeted with a great deal of enthusiasm. And in the few weeks that we have been working in the new format, it has been enthusiastically endorsed. For the countless staff members involved, the challenge of change has become the challenge of deciding how to best work with these new and creative concepts.

I wish I had the space in this blog to tell you about more of the many other innovative aspects of these exciting new plans. I hope to do so in the months ahead, as well as provide you with updates on how the new systems are functioning.

I truly believe that soon we will see that our hard work and intense efforts have reaped significant results; that we have become more efficient and more effective, ensuring that the Hadassah Medical Organization will be even more capable of providing our patients with superb clinical care, assuring the next generation of medical professionals an outstanding education and continuing to produce lifesaving research to benefit people everywhere.

I also know that where ever we may be, all of us who call ourselves Hadassah remain profoundly dedicated to the convictions that have propelled us forward from our earliest days and deeply determined to assure that our future will be even more glorious than our past.

May the year 5774 be filled with Health, Happiness and Peace.

Avigdor Kaplan, Ph.D.

Medical Divisions:

  • Anesthesiology and Critical Care Medicine – Prof. Charles Weissman
  • Brain Medicine – Prof. Tamir Ben-Hur
  • Cardiovascular Medicine – Prof. Chaim Lotan
  • Emergency Medicine – Prof. Avi Rivkind
  • General Surgery and Transplants – to be determined
  • Hematology – Prof. Dina Ben-Yehuda
  • Imaging – Prof. Jacob Sosna
  • Internal Medicine – Prof. Arie Ben-Yehuda
  • Musculoskeletal Medicine – Prof. Iri Liebergall
  • Obstetrics and Gynecology – Prof. Simcha Yagel
  • Oncology – Prof. Tamar Peretz
  • Operating Room – to be determined
  • Ophthalmology – Prof. Kobi Pe'er
  • Pediatrics – Prof. Eitan Kerem
  •  

In addition, as Senior Deputy Director General of Medical Services, Dr. Yuval Weiss will be directly responsible for the following independent departments:

  • The Dept. of Clinical Microbiology and Infectious Diseases – Prof. Allon Moses
  • The Dept. of Dermatology – Prof. Arieh Ingbe
  • The Dept. of Genetic and Metabolic Diseases – Prof. Orly Elpeleg
  • The Dept. of Nuclear Medicine – Prof. Rachel Bar-Shalom
  • The Dept. of Otolaryngology (ENT), Head and Neck Surgery – Prof. Ron Eliashar
  • The Dept. of Pathology – Prof. Eli Pikarsky
Date: 9/4/2013

Her Excellency Marie Bashir Sees Bridges to Peace at Hadassah's Hospitals

Hadassah Researcher Honored with Prestigious Prize for Blood Discovery

IVF Babies: A Gift of Israel and Hadassah to Its People

Healing Garden at Hadassah's Hospitals Dedicated to Smorgon Family

International Symposium on Pancreatic Disease Headed Up by Hadassah Specialist

BioLineRx to Commence Phase 1 Stem Cell Trial at Hadassah Medical Organization

Hadassah’s Prof. Eitan Kerem Receives European Cystic Fibrosis Society 2014 Prize

Hadassah's School Awarded 2014 National Education Award

International “No Smoking Day 2014” at Hadassah's Hospitals

Mid-Workout, Hadassah Doctor Sprints to Save a Life

Going Local: Heads of Hadassah’s ERs Forge Bond with Community Pediatricians

Hadassah Doctors Initiate Medical Collaborations in Australia

Hadassah’s Innovative Cardiac Protocol Saves Man’s Life

International Orthopedic Society Invites Hadassah Medical Organization as Member

New Trial Data out of Hadassah Hospitals Show Promise for Stem Cell Treatment of ALS

Oncology Patient Raves About Exceptional Treatment at Hadassah

Ugandan HIV-Positive Orphans Saved by Hadassah Global Outreach

Growing Heart Healthy Kids in the Heart of East Jerusalem

PHOTOS: The Pope Visits Hadassah Hospitals

Prof. Alexander Margulis: Hadassah Pediatric Plastic Surgeon and Israel Navy Seal



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America